Jack R. Wands

Dr. Jack R. Wands


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Gastroenterology
Verified
Journal Article
Open access
PDF file
PMPhilippe Merle
Philippe Merle
SMSuzanne de la Monte
Suzanne de la Monte
MKMiran Kim
Miran Kim
MHMarc Herrmann
Marc Herrmann
STShinji Tanaka
Shinji Tanaka
JWJack R. Wands
Jack R. Wands
Background & Aims: The molecular pathogenesis of human hepatocellular carcinoma (HCC) is understood poorly. In some tumors, activation of the Wnt/β-catenin pathway as a result of β-catenin gene mutations has been found. However, in many other HCCs, activation of the Wnt/β-catenin pathway has been shown in the absence of such mutations. Methods: We previously have identified the upstream human Frizzled-7 receptor (FZD7) gene of this pathway. In the present study, a quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR) assay for FZD7 was developed and overexpression of FZD7 was detected in 90% of tumors, most of which were related to chronic hepatitis B virus infection. FZD7 also was overexpressed in the 6 HCC cell lines tested and functional analysis showed that FZD7 messenger RNA (mRNA) levels correlated with enhanced cellular motility. Results: Transfection of HCC cells with dominant-negative mutant constructs encoding a C-terminally truncated FZD7 protein decreased wild-type β-catenin protein accumulation and reduced cell motility. More importantly, we observed β-catenin accumulation in human HCC tumors containing the wild-type β-catenin gene in the context of high-level FZD7 expression. Conclusions: These observations suggest that the Wnt/β-catenin signal transduction pathway is involved much more commonly in the molecular pathogenesis of HCC than previously recognized because FZD7 overexpression occurred early in the disease process, stabilized wild-type β-catenin levels, and contributed to enhanced tumor cell migration.

1 August 2006 in Hepatology
Verified
Journal Article
Closed access
PDF file
CCChiara M. Cantarini
Chiara M. Cantarini
SMSuzanne M de la Monte
Suzanne M de la Monte
MPMaoyin Pang
Maoyin Pang
MTMing Tong
Ming Tong
ADAntonia D'Errico
Antonia D'Errico
JWJack R. Wands
Jack R. Wands

SMSuzanne M de la Monte
Suzanne M de la Monte
LLLisa Longato
Lisa Longato
MTMing Tong
Ming Tong
SDSarah DeNucci
Sarah DeNucci
JWJack R. Wands
Jack R. Wands
Alcohol abuse causes progressive toxicity and degeneration in liver and brain due to insulin resistance, which exacerbates oxidative stress and pro-inflammatory cytokine activation. Alcohol-induced steatohepatitis promotes synthesis and accumulation of ceramides and other toxic lipids that cause insulin resistance. Ceramides can readily cross the blood-brain barrier, and ceramide exposure causes neurodegeneration with insulin resistance and oxidative stress, similar to the effects of alcohol. Therefore, in addition to its direct neurotoxic effects, alcohol misuse establishes a liver-brain axis of neurodegeneration mediated by toxic lipid trafficking across the blood-brain barrier, leading to progressive white matter degeneration and cognitive impairment.

1 May 2006 in Hepatology
Verified
Journal Article
Closed access
PDF file
MBMark Branda
Mark Branda
JWJack R. Wands
Jack R. Wands

13 January 2023 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MKMarkos Kalligeros
Markos Kalligeros
AVAthanasios Vassilopoulos
Athanasios Vassilopoulos
FSFadi Shehadeh
Fadi Shehadeh
SVStephanos Vassilopoulos
Stephanos Vassilopoulos
ILIngrid Lazaridou
Ingrid Lazaridou
JWJack R. Wands
Jack R. Wands

9 February 2012 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
SMSuzanne de la Monte
Suzanne de la Monte
ZDZoltan Derdak
Zoltan Derdak
JWJack R. Wands
Jack R. Wands